Baxter International Inc. (BAX)
NYSE: BAXHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BAX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $13.14B
- Forward P/E
- 12.41
- EPS (TTM)
- -$1.21
- Dividend yield
- 0.16% ($0.04)
- Ex-dividend date
- Aug 28, 2026
- 52-week range
- 15.73 – 30.00
- Day range
- 24.85 – 26.08
- Volume / Avg
- 4.32M / 6.38M
- Beta
- —
- Shares outstanding
- 517.35M
52-week range
BAX stock today
Baxter International (BAX) closed at $25.39 on Nov 20, essentially unchanged from the prior close, versus the S&P 500's 3.70% decline. Shares are 15.4% below their 52-week high of $30.00, set on Jul 30, 2026 and 61.4% above the 52-week low of $15.73, in the middle of the past year's range. BAX is up 32.9% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 38.7%.
Baxter International has posted a net loss over the last twelve months (EPS of -$1.21), so its P/E ratio is not meaningful. Baxter International pays an annual dividend of $0.04 per share, a 0.16% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Baxter International
Company profileBaxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Andrew P. Hider
- Headquarters
- Deerfield, IL
- Employees
- 37,500
- Website
- baxter.com
Financial highlights
Full financialsIn fiscal 2025, Baxter International generated $11.24 billion in revenue, up 5.7% from fiscal 2024, its 3rd consecutive year of revenue growth. Baxter International reported a net loss of $957.0 million, compared with a loss of $649.0 million a year earlier. Gross margin was 30.1% (down from 37.5%) and operating margin -2.7%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $11.24B | $10.64B | $10.36B | $10.06B | $12.15B |
| Growth | +5.72% | +2.66% | +3.01% | -17.20% | +4.05% |
| Net income | $-957.00M | $-649.00M | $2.66B | $-2.43B | $1.28B |
| EPS (diluted) | $-1.87 | $-1.27 | $5.23 | $-4.83 | $2.53 |
Analyst forecast
ForecastConsensus (15 analysts)
hold
Avg. price target
$27.25+7.33%
- Strong buy 1
- Buy 1
- Hold 12
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Oct 29, 2026
- EPS actual vs est.
- $0.57 vs $0.51
- Surprise
- +11.76%
Dividends
Dividend history- Annual dividend
- $0.04
- Dividend yield
- 0.16%
- Last payment
- $0.01
- Ex-dividend date
- Aug 28, 2026
BAX news
All BAX news- Baxter International Inc. Outlines Turnaround Progress and Updates 2026 GuidanceNasdaqBAX, UHAL.B
- Baxter: 3 Key Takeaways for Long-Term InvestorsNasdaqBAX, HEI.A
- Baxter International Reaches Analyst Target PriceNasdaq
- What Baxter International (BAX) Said on Its Q3 Earnings CallNasdaq
- Baxter International Inc. 2026 Q3 - Results - Earnings Call PresentationSeeking Alpha
- Baxter (BAX) Q3 2026 Earnings Call TranscriptNasdaq
- Baxter International Inc. Reports Third-Quarter 2026 Results and Declares Quarterly Cash Dividend of $0.01 Per ShareNasdaq
- Baxter International Inc. (BAX) Q3 2026 Earnings Call TranscriptSeeking Alpha
Baxter International peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PENPenumbra Inc. | 319.12 | -0.28% | $12.58B | vs BAX |
| GKOSGlaukos Corporation | 237.31 | -0.33% | $14.05B | vs BAX |
| SOLVSolventum Corporation | 84.50 | -1.52% | $14.36B | vs BAX |
| PODDInsulet Corporation | 133.17 | -2.96% | $9.24B | vs BAX |
| GMEDGlobus Medical Inc. Class A | 66.89 | -2.49% | $8.86B | vs BAX |
| TFXTeleflex Incorporated | 161.58 | -1.11% | $6.41B | vs BAX |
| HAEHaemonetics Corporation | 120.16 | -0.17% | $5.47B | vs BAX |
| MMSIMerit Medical Systems Inc. | 84.34 | -0.08% | $5.05B | vs BAX |
Indexes, lists and sector
Baxter International stock FAQ
What is Baxter International's stock price today?
BAX last traded at $25.39 as of Nov 20, 4:00 PM EST, up 0.00% on the day. Prices are delayed at least 15 minutes.
Does Baxter International pay a dividend?
Yes. Baxter International pays $0.04 per share annually, a 0.16% yield. The most recent dividend of $0.01 had an ex-dividend date of Aug 28, 2026.
Is Baxter International in the S&P 500?
Yes. Baxter International (BAX) is a constituent of the S&P 500 index.
Who is Baxter International's CEO?
Mr. Andrew P. Hider is the chief executive officer of Baxter International Inc., which has about 37,500 employees.
Has BAX ever split its stock?
Yes. The most recent BAX stock split was a 1841-for-1000 split on Jul 1, 2015, one of 5 splits on record.
What is the BAX 52-week high?
The 52-week high for BAX is $30.00 and the 52-week low is $15.73. The stock is currently 15.4% below its high.